The goal of this observational study is to evaluate the clinical performance of VeriSee GLC for identifying glaucoma suspects using color fundus images in adult participants. The main questions it aims to answer are:
* What are the sensitivity and specificity of VeriSee GLC for detecting glaucoma suspects based on fundus images?
* How does the performance of VeriSee GLC compare with the reference standard defined by the majority consensus of three independent evaluators?
Researchers will compare the screening results generated by VeriSee GLC with the reference standard to assess its diagnostic performance.
This retrospective study will use previously collected fundus images. VeriSee GLC performs automated image analysis to identify glaucomatous signs, including retinal nerve fiber layer (RNFL) defects, vertical cup-to-disc ratio (VCDR) enlargement, and rim-to-disc ratio (RDR) changes. The output is intended to assist healthcare professionals in identifying glaucoma suspects for referral, rather than providing a definitive diagnosis.
Protocol Amendment History
1 amendment
This ClinicalTrials.gov record has been amended once since 2026-04-22.